Point Biopharma Global Inc Revenue per Employee (PNT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Point Biopharma Global Inc   (NASDAQ: PNT)
 

Point Biopharma Global Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Point Biopharma Global Inc 's Revenue per employee grew on a trailing twelve month basis to $ 2,436,927, below the company average.
Within the Healthcare sector Employees of 7 other companies have achieved higher revenue per employee. While Point Biopharma Global Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 150. Point Biopharma Global Inc has 100 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PNT Revenue per Employee (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Revenue Change - - - - -
Sales per Employee (TTM) $ 2,436,927 2,409,027 2,360,368 2,265,796 -
PNT's Total Ranking # 150 # 0 # 0 # 0 # 0
Seq. Revenue Change -42.66 % -48.55 % -95.83 % - -

PNT Company Profile >> Back to PNT Efficiency Comparisons >> Compare PNT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 3
Healthcare Sector # 8
Overall Market # 150

Revenue per Employee Statistics
High Average Low
$ 4,873,854 $ 4,873,854 $ 4,873,854
(Sep 30 2023)  



Financial Statements
Point Biopharma Global Inc 's Revenue MRQ $ 3 Millions Visit PNT's Income Statement
Point Biopharma Global Inc 's Revenues TTM $ 244 Millions Visit PNT's aggregate revenue growth
What are PNT's Sales? Visit PNT's Sales by Segment




Other Ratios
Point Biopharma Global Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PNT's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PNT's Competitors
Revenue per Employee for PNT's Suppliers
Revenue per Employee for PNT's Customers

You may also want to know
PNT's Sales Growth Rates PNT's Pe Price to earnings ratio PNT's Receivables Turnover Ratio PNT's Stock Quote
PNT's Net Income Growth Rates PNT's Ps Price to Sales ratio PNT's Sales per Employee PNT's Asset Turnover Ratio
PNT's Net Margin PNT's Pb Price to Book ratio PNT's Financial Strength Ratios PNT's Dividend Payout Ratio
Date modified: 2026-06-22T16:30:32+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2023Number of Employees Sep 30 2023
Community Health Systems Inc   4,016,129.03 $ 12,450.000  Million 3,100 
P3 Health Partners Inc   3,680,395.69 $ 1,177.727  Million 320 
Illumina Inc   3,489,062.50 $ 4,466.000  Million 1,280 
Pulmatrix Inc   3,402,000.00 $ 6.804  Million 2 
Prophase Labs Inc   3,258,000.00 $ 61.902  Million 19 
Assertio Holdings inc   3,196,924.53 $ 169.437  Million 53 
Spero Therapeutics Inc   3,107,960.00 $ 77.699  Million 25 
Equillium Inc   3,045,142.86 $ 42.632  Million 14 
Ligand Pharmaceuticals Incorporated  2,771,446.81 $ 130.258  Million 47 
Akumin Inc   2,762,887.64 $ 737.691  Million 267 
Arcturus Therapeutics Holdings Inc   2,668,801.80 $ 296.237  Million 111 
Shockwave Medical Inc   2,649,292.49 $ 670.271  Million 253 
Telesis Bio Inc   2,515,454.55 $ 27.670  Million 11 
Cue Health Inc   2,486,437.50 $ 198.915  Million 80 
Point Biopharma Global Inc   2,436,926.76 $ 243.693  Million 100 
Xeris Biopharma Holdings Inc   2,348,738.46 $ 152.668  Million 65 
Petros Pharmaceuticals inc   2,328,243.33 $ 6.985  Million 3 
Amylyx Pharmaceuticals Inc   2,163,397.06 $ 294.222  Million 136 
Semler Scientific inc   2,158,774.19 $ 66.922  Million 31 
Prothena Corporation Public Limited Company  2,104,134.33 $ 140.977  Million 67 
Scilex Holding Company  2,097,500.00 $ 71.315  Million 34 
Intra cellular Therapies Inc   2,079,900.99 $ 420.140  Million 202 
Amgen Inc   2,064,076.92 $ 26,833.000  Million 13,000 
Opus Genetics Inc   2,043,142.86 $ 57.208  Million 28 
Prestige Consumer Healthcare Inc   1,975,589.47 $ 1,126.086  Million 570 
Therapeuticsmd Inc   1,952,000.00 $ 1.952  Million 1 
Moderna Inc   1,940,638.30 $ 9,121.000  Million 4,700 
Seres Therapeutics Inc   1,927,818.18 $ 127.236  Million 66 
Seagen Inc   1,916,959.17 $ 2,300.351  Million 1,200 
Catalyst Pharmaceuticals Inc   1,914,247.25 $ 348.393  Million 182 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.